NextRNA Therapeutics
Cambridge, US · Founded 2019 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
CA
Carl A. NovinaDirector
EA
Elena A. ProkupetsDirector
BA
Barry A. PoliskyDirector
AA
Andrea A. ArmstrongDirector
AA
Arthur A. BeckerDirector
DA
Dominique A. VerhelleDirector
MA
Marc A. CohenExecutive Officer, Director
CA
Christine A. HendersonDirector
SA
Susan A. LangerDirector
FA
Fred A. MermelsteinDirector
KA
Kenneth A. AndersonDirector
DA
Drew A. DennisonDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$23.4MraisedJan 2022 · 34 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Carl A. NovinaDirector
- Elena A. ProkupetsDirector
- Barry A. PoliskyDirector
- Andrea A. ArmstrongDirector
- Arthur A. BeckerDirector
- Dominique A. VerhelleDirector
- Marc A. CohenExecutive Officer, Director
- Christine A. HendersonDirector
- Susan A. LangerDirector
- Fred A. MermelsteinDirector
- Kenneth A. AndersonDirector
- Drew A. DennisonDirector
- Malcolm A. SalterDirector
- Julia A. NovinaExecutive Officer
- Alain A. CohenDirector
- Offering amount
- $50M
- Amount sold
- $23.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.